The Benefits and Respective Side-Effects of PE Therapy for Intractable Kawasaki Disease

Area of Science:

• Pediatric rheumatology
• Immunology
• Cardiovascular pathology

Background:

• Kawasaki disease (KD) is a leading cause of acquired heart disease in children.
• Intravenous immunoglobulin (IVIG) is the first-line treatment, but 10% of patients are refractory.
• Persistent inflammation in KD can lead to coronary artery lesions (CALs) and long-term sequelae.

Purpose of the Study:

• To describe the pathophysiology of Kawasaki disease.
• To introduce plasma exchange (PE) as a therapeutic option for IVIG-refractory KD.
• To highlight the potential of early PE intervention in preventing CALs.

Main Methods:

• Review of Kawasaki disease pathophysiology, focusing on hyper-cytokine states.
• Description of plasma exchange (PE) as a method to mitigate hyper-cytokinesis.
• Analysis of treatment outcomes for PE in IVIG-refractory KD patients.

Main Results:

• Plasma exchange effectively calms the hyper-cytokine state associated with KD.
• PE demonstrates outstanding treatment results in patients refractory to IVIG therapy.
• Early initiation of PE before CALs appear is associated with significant positive outcomes.

Conclusions:

• Plasma exchange is a potent therapeutic option for IVIG-refractory Kawasaki disease.
• Early intervention with PE is crucial for suppressing inflammation and preventing coronary artery lesions.
• PE should be strongly considered as an additional treatment for severe KD cases.